IMPROVEMENT OF DISSOLUTION PROPERTIES OF ALBENDAZOLE FROM DIFFERENT METHODS OF SOLID DISPERSION
SOLID DISPERSION METHOD
Abstract
Poor aqueous solubility of drugs results in poor absorption and bioavailability. The objective of Solid dispersion technology is to increase the dissolution properties of highly lipophilic drugs, by using different hydrophilic carriers thereby improving their bioavailability. This technology is useful for enhancing the dissolution, absorption and therapeutic efficacy of drugs in dosage forms. Albendazole is a broad-spectrum antihelminthic agent used for the treatment of a variety of parasitic worm infestations. It is practically insoluble in water but slightly soluble in solvents like chloroform, methanol, ethyl acetate, and acetonitrile. The aim of our study was to improve the dissolution profile of Albendazole using HPMC K 100 LV, Kollidon VA64 and Mannitol as carriers by solid dispersion techniques. From the prepared solid dispersion, formulation code CSF5 showed better result where carrier was HMPC K 100 LV at 1:10 ratio in solvent evaporation method. Among the carrier used here to conduct our study, HPMC K 100 LV showed better result for both kneading and solvent evaporation methods. And among the method employed here, solvent evaporation method showed better solubility of drug at 60 min also at 1:10 ratio which was 78.86%.
DOI
https://doi.org/10.22270/jddt.v8i5.1942References
2. Abdul-Fattah AM, Bhargava HN., Preparation and in vitro evaluation of solid dispersions of halofantrine, International Journal of Pharmaceutics, 2002; 235(2):17–33. DOI: 10.1016/S0378-5173(01)00941-3
3. Sinha S, Ali M, Baboota S, Ahuja A, Kumar A, Ali J., Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir, AAPS Pharm SciTech, 2010;11(2):518–527. DOI: 10.1208/s12249-010-9404-1
4. Jahan K, Sultana Z, Karim S, Ali H, Uddin J., Enhancement of dissolution properties of poorly water soluble drug loratadineby using different techniques of solid dispersion, World Journal of Science and Engineering, 2017; 2(1):103-108
5. Horter D, Dressman JB., Physiochemical properties on dissolution of drug in the gastrointestinal tract, Advance Drug Delivery Review, 1997; 25:3-14. DOI: 10.1016/S0169-409X(00)00130-7
6. Ahuja N, Katare OP, Singh B., Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water soluble drug using water soluble carriers, European Journal of Pharmaceutics and Biopharmaceutics, 2007; 65:26-38. DOI: 10.1016/j.ejpb.2006.07.007
7. Srinarong P, Faber JH, Visser MR, Hinrichs WLJ, Frijlink HW., Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of super disintegrates, European Journal of Pharmaceutics and Biopharmaceutics, 2009; 73:154-61. DOI: 10.1016/j.ejpb.2009.05.006
8. Albendazole, Drugs.com. The American Society of Health-System Pharmacists. Archived from the original on September 23, 2015. Retrieved August 18, 2015.
9. Finch Roger G.; Greenwood David; Whitley Richard J.; Norrby S. Ragnar., Antibiotic and Chemotherapy E-Book. Elsevier Health Sciences. p. 101. ISBN 978-0-7020-4765-7, 2010.
10. Patel MM, Patel DM., Fast dissolving Valdecoxib tablets containing solid dispersion of Valdecoxib, Indian Journal of Pharmaceutical Science, 2006; 68(2):222-226. DOI: 10.4103/0250-474X.25719
11. Habib M.J., Pharmaceutical solid dispersion Technology, Technomic Publishing Company, Inc. Lancaster, Pennsylvania (U.S.A.). 2001, pp. 1-36.
12. Nelson E., Knoechel E.L., Hamlin W.E., Wagner J.G., Influence of the absorption rate of tolbutamide on the rate of decline of blood sugar levels in normal humans, International Journal of Pharmaceutics, 1962; 51:509-514. DOI: 10.1002/jps.2600510603
13. Lin S.L., Lachman L., Swartz C.J., Heubner C.F., Pre-formulation investigation I. Relation of salt forms and biological activity of an experimental antihypertensive. Journal of Pharmaceutical Sciences, 1972; 61(9):1418-1422. DOI: 10.1002/jps.2600610915
Published
Abstract Display: 1719 
PDF Downloads: 1392 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.